245 related articles for article (PubMed ID: 16709544)
1. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
Bae HG; Sung H; Kim MN; Lee EJ; Koo Lee S
Scand J Infect Dis; 2006; 38(5):383-6. PubMed ID: 16709544
[TBL] [Abstract][Full Text] [Related]
2. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
[TBL] [Abstract][Full Text] [Related]
3. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.
Herrero IA; Issa NC; Patel R
N Engl J Med; 2002 Mar; 346(11):867-9. PubMed ID: 11893808
[No Abstract] [Full Text] [Related]
4. [Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
Afşar I; Barış I; Sener AG; Köksal V; Demirci M
Mikrobiyol Bul; 2012 Jul; 46(3):516-8. PubMed ID: 22951666
[TBL] [Abstract][Full Text] [Related]
5. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
6. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
Rahim S; Pillai SK; Gold HS; Venkataraman L; Inglima K; Press RA
Clin Infect Dis; 2003 Jun; 36(11):E146-8. PubMed ID: 12766857
[TBL] [Abstract][Full Text] [Related]
7. First linezolid- and vancomycin-resistant Enterococcus faecium strain in Taiwan.
Liao CH; Tseng SP; Fang CT; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2005 Apr; 55(4):598-9. PubMed ID: 15728149
[No Abstract] [Full Text] [Related]
8. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.
Raad II; Hanna HA; Hachem RY; Dvorak T; Arbuckle RB; Chaiban G; Rice LB
Antimicrob Agents Chemother; 2004 Sep; 48(9):3583-5. PubMed ID: 15328133
[TBL] [Abstract][Full Text] [Related]
9. Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis.
Souli M; Sakka V; Galani I; Antoniadou A; Galani L; Siafakas N; Zerva L; Fytrou H; Tsiodras S; Giamarellou H
Int J Antimicrob Agents; 2009 Feb; 33(2):137-42. PubMed ID: 19013056
[TBL] [Abstract][Full Text] [Related]
10. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
Till M; Wixson RL; Pertel PE
Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
[TBL] [Abstract][Full Text] [Related]
11. Linezolid resistant enterococcus faecium.
McNicholas S; Hanahoe B; Higgins F; McAnena O; Corbett-Feeney G; Cormican M
Ir Med J; 2008; 101(7):225-6. PubMed ID: 18810787
[No Abstract] [Full Text] [Related]
12. Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.
Bonora MG; Solbiati M; Stepan E; Zorzi A; Luzzani A; Catania MR; Fontana R
J Clin Microbiol; 2006 Mar; 44(3):1153-5. PubMed ID: 16517918
[TBL] [Abstract][Full Text] [Related]
13. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
Dobbs TE; Patel M; Waites KB; Moser SA; Stamm AM; Hoesley CJ
J Clin Microbiol; 2006 Sep; 44(9):3368-70. PubMed ID: 16954275
[TBL] [Abstract][Full Text] [Related]
15. Emerging linezolid-resistant, vancomycin resistant Enterococcus faecium from a patient of a haematological unit in Poland.
Krawczyk B; Samet A; Bronk M; Hellmann A; Kur J
Pol J Microbiol; 2004; 53(3):193-6. PubMed ID: 15702920
[TBL] [Abstract][Full Text] [Related]
16. Quinupristin-dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: efficacy and development of resistance.
Chong YP; Lee SO; Song EH; Lee EJ; Jang EY; Kim SH; Choi SH; Kim MN; Jeong JY; Woo JH; Kim YS
Scand J Infect Dis; 2010 Jul; 42(6-7):491-9. PubMed ID: 20524781
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.
Pai MP; Rodvold KA; Schreckenberger PC; Gonzales RD; Petrolatti JM; Quinn JP
Clin Infect Dis; 2002 Nov; 35(10):1269-72. PubMed ID: 12410489
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing.
Saager B; Rohde H; Timmerbeil BS; Franke G; Pothmann W; Dahlke J; Scherpe S; Sobottka I; Heisig P; Horstkotte MA
Eur J Clin Microbiol Infect Dis; 2008 Sep; 27(9):873-8. PubMed ID: 18421487
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin.
Noskin GA; Siddiqui F; Stosor V; Kruzynski J; Peterson LR
Clin Infect Dis; 1999 Mar; 28(3):689-90. PubMed ID: 10194104
[No Abstract] [Full Text] [Related]
[Next] [New Search]
